Aktivo Labs provides a real-time digital health platform that enables enterprises and governments to build scalable, evidence-based health and well-being solutions.

Aktivo Labs

Aktivolabs was founded to provide a product that objectively measures the healthiness of our lifestyle in a meaningful way, to let us make informed choices on how we could and should live!

Aktivo is a leap forward in personal digital wellness, where each user's lifestyle choices are met with an equally personalised awareness.

HH Family

Seeds Capital

Adaptive Capital Partners

Govin Capital Pte Ltd

Mitsui & Co

Congratulations to our entire Aktivo Labs team for their tremendous efforts! Excited to share the news of our inclusion in the prestigious ITC DIA Europe Top100 #Insurtechs to watch in 2024.

Proud to be recognised by the The ITC DIA Europe Community for our great achievements. https://lnkd.in/dSE94JkS

#ITCDIABCN #ITCDIAMUC #ITCDIAEU #ITCDIACommunity #ITCDIAEUROPE #Insurtech

Gourab Mukherjee Jonathan Knapp Janicia Koh Bhavik Bhatt Avinash Johnson (Jonnie) Hemant Kumar Vinod Mukundan Hariom singh Shwetika Kumar Lars Heinig Glenna Fong

Aktivo Labs featured amongst 15 top Health & Insurance tech companies in Singapore 

Thanks for the recognition, F6S!

"Founded and run by a team of clinicians, data scientists, and digital health experts, Aktivo Labs has scientifically developed a low-touch, highly scalable population health management platform."

Our mission to empower life and health insurers to engage high-value customers, optimize risk management, and foster meaningful interactions  continues. We remain committed to delivering exceptional value to our partners and their customers.

Gourab Mukherjee Jonathan Knapp Bhavik Bhatt Glenna Fong

Connect with us as we embark on this exciting journey! 🌏🇸🇬🇦🇺

As highlighted by Haymarket HQ, Aktivo Labs empowers governments and enterprises to predict, prevent, and manage chronic diseases at scale with evidence-based, technology-driven solutions. We’ve impacted over 1.5 million users globally through dynamic partnerships with health insurance companies to transform health outcomes and improve lives.

We're thrilled to bring our innovation to the Australian market and share more updates on this journey. Stay connected with us here or visit https://aktivolabs.com/ to learn more about our mission and solutions!

Gourab Mukherjee Jonathan Knapp Bhavik Bhatt Daniel Posavac Shivajee Dewangan Glenna Fong 

#AktivoLabs #GlobalExpansion #HealthTech #ChronicDiseasePrevention #Innovation #GIAAccelerator #SingaporeTech #AustraliaMarket #HaymarketHQ

Get ready to byte into #HealthTech with Aktivo Labs' Chief Technology Officer, Avinash Johnson (Jonnie), at MongoDB.local Singapore on August 22, 2024, at 2 PM. 

He’ll be decoding our journey in "Building Digital Health Solutions and Peeling the #MongoDB Onion." Discover how we built the Aktivo® Score and get the lowdown on how our #tech stack is powering up real-time health data analytics and driving groundbreaking innovations. 

Don’t miss out on this data-driven deep dive! https://lnkd.in/gjdTVJZK

Gourab Mukherjee Jonathan Knapp Bhavik Bhatt Vinod Mukundan

We’re thrilled to share our participation in the GIA Singapore-Australia Market Accelerator (SAMA), an initiative by Haymarket HQ and Enterprise Singapore focused on accelerating expansion in Australia.

Our journey involved refining our pitch for the Australian market, expertly guided by Kim Lovely. Additionally, we explored significant opportunities in Victoria and NSW, thanks to introductions by Mike Baird and Cassy X.

A special thank you to Duco van Breemen, Terry Hilsberg, and Andrea Plawutsky GAICD from Haymarket HQ for organizing such an enriching experience. We look forward to joining the Trade Mission in Sydney and Melbourne this September. Stay tuned for more updates on our journey down under!

Gourab Mukherjee Jonathan Knapp Daniel Posavac Shivajee Dewangan Glenna Fong

#AustralianMarketEntry #GlobalExpansion #EnterpriseSingapore #TradeMission #Innovation #HealthTech #AktivoLabs

“We need to do much more than boost longevity for its own sake and instead pursue the specific goal of increasing the number of extra years we experience when we are independent, free of chronic disease and wealthy enough to lead fulfilling lives.”

At Insurtech Insights USA, Nutan Joshi had an enlightening chat with our CEO, Gourab Mukherjee, exploring how Aktivo Labs is reshaping digital health. 

With offices in New York, the UK, India, Singapore, Tokyo, and the Philippines, we're committed to enhancing well-being globally. Don’t miss this insightful interview to learn more about our journey!

Aktivo Labs Achieves SOC 2 Type II Compliance!

We're excited to announce that Aktivo Labs has progressed from SOC 2 Type I to SOC 2 Type II compliance! This milestone demonstrates our steadfast commitment to data security and robust internal controls, enhancing trust with our clients and partners.

SOC 2 Type II goes beyond Type I by rigorously testing our systems over an extended period, ensuring our controls are effective over time. This comprehensive assessment validates our ongoing efforts to maintain the highest standards in data security.

Thank you to our team for their hard work and to our clients and partners for their continued support. We look forward to advancing our standards of excellence in data security.

#SOC2Type2 #BeyondCompliance #DataSecurity #TechInnovation

Hemant Kumar Avinash Johnson (Jonnie) Gourab Mukherjee Jonathan Knapp Bhavik Bhatt

At the MassChallenge FinTech Program Showcase, where we explored the latest in #FinTech innovations and connected with industry leaders.

Metric
Company Name	Aktivo Labs
Symbol
MSH ID	COM:AKTIVOLABS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Digital Health Technology
Country	SG
Stage
Employee Count
Website	aktivolabs.com
LinkedIn	aktivo-labs
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:AKTIVOLABS

Aktivo Labs

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue